Pinaki P. Banerjee

The University of Texas MD Anderson Cancer Center

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors”.

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

New England Journal of Medicine(2020)10.1056/nejmoa1910607

N/A

5.4DataRank · unranked

2164 citations

David Marín, Pinaki P. Banerjee, Homer A. Macapinlac, Philip A. Thompson, Rafet Başar +22 more

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

Nature Medicine(2024)10.1038/s41591-023-02785-8

N/A

4.0DataRank · unranked

468 citations

Ye Li, Rafet Başar, Hind Rafei, May Daher, Jinzhuang Dou +31 more

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

Blood(2021)10.1182/blood.2021013290

N/A

2.6DataRank · unranked

87 citations

Pinaki P. Banerjee, Denái R. Milton, Xianli Jiang, Christina Ganesh, Sajad Khazal +24 more

Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation

Journal of Clinical Oncology(2021)10.1200/jco.20.02608

N/A

2.1DataRank · unranked

66 citations

Ruitao Lin, David Marín, Hind Rafei, Mustafa Bdiwi, Peter F. Thall +38 more

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

Blood(2021)10.1182/blood.2020007748

N/A

0.848DataRank · unranked

284 citations

Rafet Basar, Elif Gokdemir, Natalia Baran, Nadima Uprety, Ana Karen Nunez Cortes +56 more

Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells

Journal of Clinical Investigation(2021)10.1172/jci142116

N/A

0.832DataRank · unranked

255 citations

Mayra Shanley, Rafet Başar, May Daher, Joy Gumin, Daniel B. Zamler +45 more

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0164

N/A

0.757DataRank · unranked

154 citations

Nancy D. Marín, Mecit Kaplan, Pinaki P. Banerjee, Melissa M. Berrien-Elliott, Michelle Becker‐Hapak +38 more

Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering

Science Advances(2023)10.1126/sciadv.add6997

N/A

0.704DataRank · unranked

108 citations

Vakul Mohanty, Jinzhuang Dou, Yuefan Huang, Pinaki P. Banerjee, Qi Miao +25 more

CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0096

N/A

0.609DataRank · unranked

57 citations

Rafet Başar, May Daher, Hind Rafei, Ping Li, Nadima Uprety +42 more

CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells

Nature(2025)10.1038/s41586-025-09087-8

N/A

0.587DataRank · unranked

49 citations

Rafet Başar, Sunil Acharya, Yu-Sung Hsu, Pinghua Liu, Deqiang Zhang +53 more

Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency

Cancer Cell(2025)10.1016/j.ccell.2025.07.021

N/A

0.553DataRank · unranked

39 citations

Rafet Başar, Jeong-Min Park, Nadima Uprety, Rejeena Shrestha, Francia Reyes Silva +31 more

Activated B cells suppress T-cell function through metabolic competition

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005644

N/A

0.542DataRank · unranked

36 citations

Rafet Başar, Yuefan Huang, Fang Wang, Natalia Baran, Pinaki P. Banerjee +22 more

Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy

Cell Reports(2021)10.1016/j.celrep.2021.109432

N/A

0.533DataRank · unranked

34 citations

Nadima Uprety, Emily L. Ensley, May Daher, Kimberly Klein, Fernando D. Martínez +29 more

Anti–miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response

Journal of Clinical Investigation(2023)10.1172/jci158348

N/A

0.529DataRank · unranked

33 citations

Enrique Fuentes‐Mattei, Melanie Winkle, Keishi Okubo, Recep Bayraktar, Erik Knutsen +34 more

BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML

Science Translational Medicine(2024)10.1126/scitranslmed.adp0004

N/A

0.524DataRank · unranked

32 citations

Anand K. Singh, Rafet Başar, Nadima Uprety, Ye Li, Huihui Fan +45 more

Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells

Cell Reports(2025)10.1016/j.celrep.2024.115122

N/A

0.385DataRank · unranked

12 citations

Achintyan Gangadharan, Pinaki P. Banerjee, Ye Li, Andy G.X. Zeng, Hind Rafei +18 more

Phase I/II study of TROP2 CAR engineered IL15-transduced cord blood-derived NK cells delivered intraperitoneally for the management of platinum resistant ovarian cancer, mesonephric-like adenocarcinoma, and pancreatic cancer.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps5626

N/A

0.345DataRank · unranked

9 citations

Hind Rafei, Rafet Başar, Pinaki P. Banerjee, Zeyad Metwalli, Kathryn Lito +13 more

Natural killer cells’ functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes

Nature Communications(2025)10.1038/s41467-025-58662-0

N/A

0.321DataRank · unranked

7 citations

Irene Gañán‐Gómez, Bijender Kumar, Natthakan Thongon, Feiyang Ma, Kelly S. Chien +35 more

CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models

Blood Cancer Discovery(2025)10.1158/2643-3230.bcd-25-0130

N/A

0.279DataRank · unranked

5 citations

Sunil Acharya, Francia Reyes-Silva, Rafet Başar, Nadima Uprety, Luz Yurany Moreno Rueda +24 more

CIS checkpoint deletion enhances the fitness of cord blood derived natural killer cells transduced with a chimeric antigen receptor

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.29.014472

N/A

0.224DataRank · unranked

2 citations

Rafet Basar, Elif Gokdemir, Natalia Baran, Nadima Uprety, Ana Karen Nunez Cortes +55 more

Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia

Frontiers in Immunology(2022)10.3389/fimmu.2022.1018047

N/A

0.208DataRank · unranked

3 citations

Vahid Afshar‐Kharghan, Mayela Carolina Mendt, Robert Sackstein, Mark R. Tanner, Uday Popat +19 more

Data from Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

(2023)10.1158/1078-0432.c.6530711.v1

N/A

0.104DataRank · unranked

1 citations

Nancy D. Marín, Mecit Kaplan, Pinaki P. Banerjee, Melissa M. Berrien-Elliott, Michelle Becker‐Hapak +38 more

Clinical, immunologic, and genetic characteristics of 148 patients with natural killer cell deficiency

Journal of Allergy and Clinical Immunology(2025)10.1016/j.jaci.2025.01.030

N/A

0DataRank · unranked

9 citations

Evelyn R. Hernandez, Luis Alberto Pedroza, Iván K. Chinn, Lisa Forbes Satter, Nicholas L. Rider +13 more

Human NK cell deficiency as a result of biallelic mutations in MCM10

Journal of Clinical Investigation(2020)10.1172/jci134966

N/A

0DataRank · unranked

71 citations

Silke Paust, Matilde Immacolata Conte, Ryan M. Baxley, Megan Schmit, Sagar L. Patil +23 more